Abstract
Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Keywords: Serotonin7 Receptors, amino acid
Current Medicinal Chemistry
Title: Serotonin7 Receptors (5-HT7Rs)and their Ligands
Volume: 11 Issue: 5
Author(s): M. Leopoldo
Affiliation:
Keywords: Serotonin7 Receptors, amino acid
Abstract: Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Export Options
About this article
Cite this article as:
Leopoldo M., Serotonin7 Receptors (5-HT7Rs)and their Ligands, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455828
DOI https://dx.doi.org/10.2174/0929867043455828 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Current Respiratory Medicine Reviews Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders
Current Topics in Medicinal Chemistry Stationary Wavelet Transform and AdaBoost with SVM Based Pathological Brain Detection in MRI Scanning
CNS & Neurological Disorders - Drug Targets Angiogenesis Inhibition in the Treatment of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Cysteine-, Methionine- and Seleno-Cysteine-Proline Chimeras: Synthesis and Their Use in Peptidomimetics Design
Current Bioactive Compounds Increased Expression of the Remodeling- and Tumorigenic-Associated Factor Osteopontin in Pyramidal Neurons of the Alzheimers Disease Brain
Current Alzheimer Research Bulimia Nervosa and Alcohol Use Disorder: Evidence for Shared Etiology and Neurobiology
Current Psychiatry Reviews Purification and Partial Characterization of a Lectin from Canavalia Grandiflora Benth. Seeds
Protein & Peptide Letters The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application
Current Pharmaceutical Design Pre-Dementia Diagnosis of Alzheimers Disease: Translating Clinicobiologic Research into Practice
Current Psychiatry Reviews Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Anti-Cancer Agents in Medicinal Chemistry Systematic Review of the Role of Microparticles in Systemic Sclerosis
Current Rheumatology Reviews Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance
Current Pharmaceutical Design Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science Statistical Identification of Gene-gene Interactions Triggered By Nonlinear Environmental Modulation
Current Genomics Regulation of the Unfolded Protein Response in Disease: Cellular Stress and microRNAs
Current Immunology Reviews (Discontinued) Structural Analysis for Colchicine Binding Site-Targeted ATCAA Derivatives as Melanoma Antagonists
Medicinal Chemistry Managing Acute Agitation and Psychotic Symptoms in the Emergency Department
Adolescent Psychiatry